Today’s top gainers include the company Gilead Sciences, Inc. (NASDAQ:GILD) which is in the industry Biotechnology, gaining -0.12% today. In the last week its performance is -3.42%, and -7.66% for the past quarter. Currently, Gilead Sciences, Inc., GILD has a target price of 78.59, so today’s gain of -0.12% is a significant step towards its target price. The GAP today is therefore -0.09%.
Gilead Sciences, Inc. (NASDAQ:GILD), has a market cap of 85.05 B, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 79.40%.
At the current price of 64.43, it has a dividend yield of 3.23%, and its target price is 78.59. This is with a profit margin of 43.40%, and total debt/equity of 0. Gilead Sciences, Inc. (NASDAQ:GILD) has a P/E of 6.81, as well as a forward P/E of 8.67.
With a current EPS of 9.46, and a forecasted EPS growth for next year at -9.45%,Gilead Sciences, Inc. (NASDAQ:GILD) has had a EPS growth for the past five years at 41.20%. For the next five years EPS growth is projected to be -5.60%.
Performance for the year is -20.23%. Since its IPO date on 1/22/1992, the total performance to date is -9.33%.
Volume today for Gilead Sciences, Inc. (NASDAQ:GILD), is 7925634, while its average volume is 7974.78. Whilst the total gain today was -0.12%, it did have a day high of -7.80%.
Volatility for this week has been at 1.26%, and 1.33% for the month. The 52-week low for Gilead Sciences, Inc., GILD has been -0.05%, while the 52-week-high has reached -26.01%.
Looking at its return of investments, which is 31.00%, and its return on assets is 22.80%. Gilead Sciences, Inc. (NASDAQ:GILD) has an operating margin of 57.60%. With a sales growth of -16.50% quarter over quarter. Bearing in mind that Gilead Sciences, Inc., GILD is in the sector Healthcare, its long-term debt/equity is 1.29, and has a current ratio of 2.6 and 2.4 for quick ratio.
So what is the value of Gilead Sciences, Inc.? Well its PEG is *TBA, and the P/S is 2.92, along with a P/B of 4.12. Meanwhile it has a p/cash of 6.03.